2020 ASBrS多学科专家组建议:乳腺手术疼痛管理

2020-08-11 美国乳腺外科医生学会 Ann Surg Oncol . 2020 Aug 11.

2020年8月,美国乳腺外科医生学会(ASBrS)发布了乳腺手术疼痛管理的多学科专家建议。文章主要针对乳腺手术术前,术中以及术后疼痛的管理提出共识指导建议。

中文标题:

2020 ASBrS多学科专家组建议:乳腺手术疼痛管理

英文标题:

Pain Management in Breast Surgery: Recommendations of a Multidisciplinary Expert Panel-The American Society of Breast Surgeons

发布日期:

2020-08-11

简要介绍:

2020年8月,美国乳腺外科医生学会(ASBrS)发布了乳腺手术疼痛管理的多学科专家建议。文章主要针对乳腺手术术前,术中以及术后疼痛的管理提出共识指导建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 ASBrS多学科专家组建议:乳腺手术疼痛管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=538f31c00195a388, title=2020 ASBrS多学科专家组建议:乳腺手术疼痛管理, enTitle=Pain Management in Breast Surgery: Recommendations of a Multidisciplinary Expert Panel-The American Society of Breast Surgeons, guiderFrom=Ann Surg Oncol . 2020 Aug 11., authorId=0, author=, summary=2020年8月,美国乳腺外科医生学会(ASBrS)发布了乳腺手术疼痛管理的多学科专家建议。文章主要针对乳腺手术术前,术中以及术后疼痛的管理提出共识指导建议。, cover=https://img.medsci.cn/2020817/1597678847309_2020535.jpg, journalId=0, articlesId=null, associationId=1811, associationName=美国乳腺外科医生学会, associationIntro=, copyright=0, guiderPublishedTime=Tue Aug 11 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年8月,美国乳腺外科医生学会(ASBrS)发布了乳腺手术疼痛管理的多学科专家建议。文章主要针对乳腺手术术前,术中以及术后疼痛的管理提出共识指导建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=106061, tagName=乳腺手术)], categoryList=[CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=89, categoryName=乳腺癌, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1771, guiderKeyword=乳腺, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=0, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7077, appHits=168, showAppHits=0, pcHits=474, showPcHits=6909, likes=5, shares=10, comments=8, approvalStatus=1, publishedTime=Mon Aug 17 23:41:12 CST 2020, publishedTimeString=2020-08-11, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Aug 17 23:40:55 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 18:14:30 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ASBrS多学科专家组建议:乳腺手术疼痛管理.pdf)])
2020 ASBrS多学科专家组建议:乳腺手术疼痛管理.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=913955, encodeId=038d9139556c, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/2BB0E90FFDA4FC816681902AA9BC71F6/100, createdBy=5b442207228, createdName=清华8035, createdTime=Tue Jan 05 20:06:12 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885389, encodeId=10d288538993, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226c4799349, createdName=654568956, createdTime=Tue Sep 15 09:20:04 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810813, encodeId=da9781081355, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25e55411955, createdName=ms5000000741733160, createdTime=Wed Aug 19 15:51:33 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809930, encodeId=c807809930b3, content=😉😉不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f4e2490464, createdName=124794a3m20(暂无昵称), createdTime=Tue Aug 18 00:10:33 CST 2020, time=2020-08-18, status=1, ipAttribution=)]
    2021-01-05 清华8035

    很棒

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=913955, encodeId=038d9139556c, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/2BB0E90FFDA4FC816681902AA9BC71F6/100, createdBy=5b442207228, createdName=清华8035, createdTime=Tue Jan 05 20:06:12 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885389, encodeId=10d288538993, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226c4799349, createdName=654568956, createdTime=Tue Sep 15 09:20:04 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810813, encodeId=da9781081355, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25e55411955, createdName=ms5000000741733160, createdTime=Wed Aug 19 15:51:33 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809930, encodeId=c807809930b3, content=😉😉不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f4e2490464, createdName=124794a3m20(暂无昵称), createdTime=Tue Aug 18 00:10:33 CST 2020, time=2020-08-18, status=1, ipAttribution=)]
    2020-09-15 654568956

    不错

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=913955, encodeId=038d9139556c, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/2BB0E90FFDA4FC816681902AA9BC71F6/100, createdBy=5b442207228, createdName=清华8035, createdTime=Tue Jan 05 20:06:12 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885389, encodeId=10d288538993, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226c4799349, createdName=654568956, createdTime=Tue Sep 15 09:20:04 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810813, encodeId=da9781081355, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25e55411955, createdName=ms5000000741733160, createdTime=Wed Aug 19 15:51:33 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809930, encodeId=c807809930b3, content=😉😉不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f4e2490464, createdName=124794a3m20(暂无昵称), createdTime=Tue Aug 18 00:10:33 CST 2020, time=2020-08-18, status=1, ipAttribution=)]
    2020-08-19 ms5000000741733160

    👍

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=913955, encodeId=038d9139556c, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/2BB0E90FFDA4FC816681902AA9BC71F6/100, createdBy=5b442207228, createdName=清华8035, createdTime=Tue Jan 05 20:06:12 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885389, encodeId=10d288538993, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226c4799349, createdName=654568956, createdTime=Tue Sep 15 09:20:04 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810813, encodeId=da9781081355, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25e55411955, createdName=ms5000000741733160, createdTime=Wed Aug 19 15:51:33 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809930, encodeId=c807809930b3, content=😉😉不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f4e2490464, createdName=124794a3m20(暂无昵称), createdTime=Tue Aug 18 00:10:33 CST 2020, time=2020-08-18, status=1, ipAttribution=)]
    2020-08-18 124794a3m20(暂无昵称)

    😉😉不错

    0

拓展阅读

2016 ACR适宜性标准:可触及的乳腺肿块

美国放射学会(ACR,American College of Radiology) · 2016-11-01

2017 SIRM建议:数字乳腺断层摄影

意大利医学放射学会(SIRM,Italian Society of Medical Radiology) · 2017-05-25

数字乳腺X线断层摄影检查技术及其诊断应用规范专家共识

数字乳腺X线断层摄影检查技术、诊断规范专家组 · 2021-06-30

2022 ESTRO共识建议:早期乳腺癌体外放疗的病患选择、剂量和分割

欧洲放射肿瘤学学会(ESTRO,European Society of Radiotherapy & Oncology) · 2021-12-30